Enabling a New Paradigm in Improving The Management of Critically Ill Patients

FloSonics Medical is a venture-backed start-up that develops and commercializes wearable sensors, which improve clinical management of critically ill patients inside and outside of the hospital. Our FloPatch technology enables real-time functional hemodynamic monitoring for patients requiring cardiopulmonary and fluid resuscitation. In the fall of 2015, FloSonics’ four cofounders approached NORCAT Innovation with their idea for the FloPatch. The group worked together with NORCAT to validate the need for the FloPatch technology, and subsequently received initial funding through NORCAT’s Innovation Acceleration Program to support the planning, development and testing of the FloPatch prototype.

As a client, FloSonics also utilized the program offerings and in-house expert advice offered by NORCAT Innovation, connecting with multiple mentors with experience in the field of medicine, product development, finance and startup growth. FloSonics’ connection with NORCAT Innovation also led to the formation of a relationship with both the NORCAT Innovation Mill Angels (NIMA) and the Northern Ontario Angels (NOA), who coached the team to a successful pitch that aided in the further development of a proof-of-concept device In the face of their success, the services provided through NORCAT Innovation remains a stand-out for the Sudbury-based FloSonics founders.

“NORCAT was a true partner; they were instrumental in launching our company. From prototyping to formal fundraising, the NORCAT Innovation team provided the experience, know how, and credibility we needed to develop a world-class start-up in the North.”

Dr. Joe Eibl
CEO and Co-founder, FloSonics Medical